These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 14346763)
1. PROMOTION OF INSULIN SECRETION BY GLUCAGON. SAMOLS E; MARRI G; MARKS V Lancet; 1965 Aug; 2(7409):415-6. PubMed ID: 14346763 [No Abstract] [Full Text] [Related]
2. High dose intravenous glucose tolerance test and serum insulin and glucagon levels in diabetic and non-diabetic cats: relationships to insular amyloidosis. O'Brien TD; Hayden DW; Johnson KH; Stevens JB Vet Pathol; 1985 May; 22(3):250-61. PubMed ID: 3890345 [TBL] [Abstract][Full Text] [Related]
3. Abnormal response of pancreatic glucagon to glycemic changes in diabetes mellitus. Ohneda A; Watanabe K; Horigome K; Sakai T; Kai Y; Oikawa S J Clin Endocrinol Metab; 1978 Mar; 46(3):504-10. PubMed ID: 752036 [TBL] [Abstract][Full Text] [Related]
4. Low insulin secretion in decompensated liver cirrhosis with diabetes mellitus. Sampelean D; Motocu M Rom J Intern Med; 1993; 31(4):265-9. PubMed ID: 8148778 [TBL] [Abstract][Full Text] [Related]
5. Diet-induced improvement of abnormalities in insulin and glucagon secretion and in insulin receptor binding in diabetes mellitus. Savage PJ; Bennion LJ; Flock EV; Nagulesparan M; Mott D; Roth J; Unger RH; Bennett PH J Clin Endocrinol Metab; 1979 Jun; 48(6):999-1007. PubMed ID: 447806 [No Abstract] [Full Text] [Related]
6. Normalization of insulin and glucagon secretion in ketosis-resistant diabetes mellitus with prolonged diet therapy. Savage PJ; Bennion LJ; Bennett PH J Clin Endocrinol Metab; 1979 Dec; 49(6):830-3. PubMed ID: 117019 [TBL] [Abstract][Full Text] [Related]
7. [Blood insulin, glucagon and glucose levels in latent diabetes mellitus determined during glucose tolerance test (effect of phenformin)]. Tikhonova NE Ter Arkh; 1982; 54(10):12-6. PubMed ID: 6758166 [No Abstract] [Full Text] [Related]
8. Independent measures of insulin secretion and insulin sensitivity during the same test: the glucagon-insulin tolerance test. Dorkhan M; Tripathy D; Malm G; Asgharian H; Tuomi T; Groop L J Intern Med; 2008 Jul; 264(1):62-71. PubMed ID: 18298489 [TBL] [Abstract][Full Text] [Related]
9. Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications. Scheen AJ; Castillo MJ; Lefèbvre PJ Diabetes Metab; 1996 Dec; 22(6):397-406. PubMed ID: 8985647 [TBL] [Abstract][Full Text] [Related]
10. Normalization of the paradoxic secretion of glucagon in diabetics who were controlled by the artificial beta cell. Shichiri M; Kawamori R; Abe H Diabetes; 1979 Apr; 28(4):272-5. PubMed ID: 374171 [TBL] [Abstract][Full Text] [Related]
11. Insulin response to glucagon. The opposing effects of diabetes and obesity. Crockford PM; Hazzard WR; Williams RH Diabetes; 1969 Apr; 18(4):216-24. PubMed ID: 5776458 [No Abstract] [Full Text] [Related]
12. Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation. Brändle M; Lehmann R; Maly FE; Schmid C; Spinas GA Diabetes Care; 2001 Jul; 24(7):1253-8. PubMed ID: 11423511 [TBL] [Abstract][Full Text] [Related]
13. Glucose modulation of insulin and glucagon secretion is altered in impaired glucose tolerance. Larsson H; Berglund G; Ahrén B J Clin Endocrinol Metab; 1995 Jun; 80(6):1778-82. PubMed ID: 7775622 [TBL] [Abstract][Full Text] [Related]
14. [The significance of the initial level and tendency of the blood sugar for the course of insulin and glucagon tolerance tests in diabetics]. MOHNIKE G; JUTZI E; KOEHLER W Dtsch Gesundheitsw; 1960 Nov; 15():2300-7. PubMed ID: 13771719 [No Abstract] [Full Text] [Related]
15. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus. Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528 [TBL] [Abstract][Full Text] [Related]
16. Acute disruption of glucagon secretion or action does not improve glucose tolerance in an insulin-deficient mouse model of diabetes. Steenberg VR; Jensen SM; Pedersen J; Madsen AN; Windeløv JA; Holst B; Quistorff B; Poulsen SS; Holst JJ Diabetologia; 2016 Feb; 59(2):363-70. PubMed ID: 26537124 [TBL] [Abstract][Full Text] [Related]
17. A longitudinal study of plasma insulin and glucagon in women with previous gestational diabetes. Damm P; Kühl C; Hornnes P; Mølsted-Pedersen L Diabetes Care; 1995 May; 18(5):654-65. PubMed ID: 8586003 [TBL] [Abstract][Full Text] [Related]
18. Beta-cell dysfunction in classic transient neonatal diabetes is characterized by impaired insulin response to glucose but normal response to glucagon. Valerio G; Franzese A; Salerno M; Muzzi G; Cecere G; Temple KI; Shield JP Diabetes Care; 2004 Oct; 27(10):2405-8. PubMed ID: 15451908 [TBL] [Abstract][Full Text] [Related]
19. [Changes in the glucagon and growth hormone levels in the blood plasma of healthy persons and of patients with disordered glucose tolerance after insulin administration]. Tikhonova NE; Alekseeva GG Probl Endokrinol (Mosk); 1986; 32(1):22-5. PubMed ID: 3513155 [TBL] [Abstract][Full Text] [Related]
20. [Symposium: interrelations among hormones. 3. Spleen: effects of the digestive tract to insulin secretion (interrelation to glucagon)]. Shima K; Kuroda K; Matsuyama T Nihon Naibunpi Gakkai Zasshi; 1970 Feb; 45():Suppl:32-3. PubMed ID: 5462204 [No Abstract] [Full Text] [Related] [Next] [New Search]